Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intellia Thera CS
(NQ:
NTLA
)
14.23
+1.12 (+8.50%)
Streaming Delayed Price
Updated: 1:43 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Intellia Thera CS
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
From GLD To TSLA: Unlocking Today’s Best Trading Opportunities
November 18, 2024
The week kicks off amidst significant market movements shaped by geopolitical and policy developments.
Via
Talk Markets
Topics
Stocks / Equities
Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
November 18, 2024
Via
Benzinga
9 Analysts Have This To Say About Intellia Therapeutics
November 11, 2024
Via
Benzinga
3 Fast-Growing Stocks Analysts See Doubling in Price
November 11, 2024
Clinical-stage biotech firms often have massive upside potential, but much of that possible success hinges on successful trials and product launches.
Via
MarketBeat
A Glimpse of Intellia Therapeutics's Earnings Potential
November 06, 2024
Via
Benzinga
Looking Into Intellia Therapeutics's Recent Short Interest
October 29, 2024
Via
Benzinga
7 Analysts Have This To Say About Intellia Therapeutics
October 25, 2024
Via
Benzinga
A Closer Look at Intellia Therapeutics's Options Market Dynamics
October 24, 2024
Via
Benzinga
Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day?
November 06, 2024
There's nothing bearish at all about what it reported recently.
Via
The Motley Fool
This Beaten-Down Stock Could Soar by 354%, According to Wall Street
November 04, 2024
Maybe the Street is a bit too optimistic on this one.
Via
The Motley Fool
12 High-Growth Stocks That Could Deliver Parabolic Returns
October 28, 2024
These 12 innovative companies could deliver exponential returns over the next quarter century.
Via
The Motley Fool
Monopar Therapeutics, Intellia Therapeutics, Capri Holdings, Western Digital, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 24, 2024
The U.S. stock market exhibited a mixed performance on Thursday. The Nasdaq Composite gained over 130 points, while the Dow traded down 0.3% to 42,374.36.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Intellia Therapeutics Stock Plummeted by 20% Today
October 24, 2024
Seemingly encouraging results from the lab were met with some notable skepticism.
Via
The Motley Fool
3 Health Care Stocks Moving In Thursday's Intraday Session
October 24, 2024
Via
Benzinga
Expert Outlook: Intellia Therapeutics Through The Eyes Of 7 Analysts
September 11, 2024
Via
Benzinga
Expert Ratings For Intellia Therapeutics
August 12, 2024
Via
Benzinga
Why Is Gene Therapy-Focused Intellia Therapeutics Stock Trading Lower On Thursday?
October 24, 2024
Intellia Therapeutics' Phase 2 data shows NTLA-2002, a CRISPR gene therapy, reduced hereditary angioedema attack rates by up to 81%, with complete responses.
Via
Benzinga
This Beaten-Down Growth Stock Could Skyrocket 234%, According to Wall Street
October 17, 2024
Intellia Therapeutics' innovative gene editing technology could revolutionize medicine, but investors need a strong stomach for volatility.
Via
The Motley Fool
2 Cathie Wood Stocks That Could Soar 32% and 282%, According to Wall Street
October 09, 2024
These stocks haven't performed well this year.
Via
The Motley Fool
2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk
September 29, 2024
The Ark Invest portfolio is known for taking aggressive bets.
Via
The Motley Fool
3 Gene Editing Stocks with Potential to Transform Medicine
August 09, 2024
Gene-editing holds substantial promise for treating thousands of diseases – creating incredible opportunities for gene editing stocks.
Via
InvestorPlace
NTLA Stock Earnings: Intellia Therapeutics Misses EPS, Misses Revenue for Q2 2024
August 08, 2024
NTLA stock results show that Intellia Therapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
August 01, 2024
The popular growth-stock investor added to these three existing positions on Wednesday.
Via
The Motley Fool
7 Biotech Stocks to Keep on Your Clinical Radar
July 23, 2024
Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs.
Via
InvestorPlace
3 Gene Editing Stocks That Could Grow Your Wealth
July 17, 2024
Investors looking for gene editing stocks of cutting edge technology firms should consider these biotech stocks.
Via
InvestorPlace
3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition
July 17, 2024
Explore gene-editing stocks with potential to become multibaggers as the industry advances in treating genetic disorders.
Via
InvestorPlace
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
July 12, 2024
Via
Benzinga
3 Profitable CRISPR Stocks Earning Analysts’ Praise
July 09, 2024
Revolutionary gene-editing technologies provide promise for investors seeking the most profitable CRISPR stocks today and in the future.
Via
InvestorPlace
The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024
July 09, 2024
Finding undervalued gene editing stocks is easy, but having the patience to stick with them is the challenge.
Via
InvestorPlace
The Bull Case for Intellia Therapeutics Stock Just Got Even Stronger
July 09, 2024
An improbable but serious risk facing the company's investors just got minimized.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.